Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wobenzym for knee osteoarthritis pain
NCT02088411Phase 2Completed
- Sponsor
- Atrium Innovations Inc.
- Start
- Nov 2000
- Primary completion
- Nov 2001
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoarthritis (OA) (3 arms), sponsored by Atrium Innovations Inc. Primary endpoint: Lequesne Functional Index at 12 weeks. Started Nov 2000; status: completed.
02
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02088411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02088411.